Ausgabe 4/2017
Current and Future Therapies in Multiple Sclerosis
Inhalt (30 Artikel)
Multiple Sclerosis: Unprecedented Progress But Significant Challenges Ahead
Devon S. Conway, Le H. Hua, Jeffrey A. Cohen
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
Jeffrey M. Gelfand, Bruce A. C. Cree, Stephen L. Hauser
Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
Laura E. Baldassari, John W. Rose
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
Burhan Z. Chaudhry, Jeffrey A. Cohen, Devon S. Conway
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Harold L. Atkins, Mark S. Freedman
The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials
Kedar R. Mahajan, Daniel Ontaneda
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
Maria Pia Sormani, Matteo Pardini
Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
Cindy J. Nowinski, Deborah M. Miller, David Cella
Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics
Lilyana Amezcua, Flavia Nelson
Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
Andrew L. Smith, Jeffrey A. Cohen, Le H. Hua
Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
Eric M. L. Williamson, Joseph R. Berger
Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding
Rhonda Voskuhl, Callene Momtazee
Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis
Marisa McGinley, Ian T. Rossman
Wellness and the Role of Comorbidities in Multiple Sclerosis
Brandon P. Moss, Mary R. Rensel, Carrie M. Hersh
Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA
Daniel M. Hartung
Therapeutic Approaches for Zika Virus Infection of the Nervous System
Rachel P. M. Abrams, Jamie Solis, Avindra Nath
The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
Andrew S. Luksik, Russell Maxwell, Tomas Garzon-Muvdi, Michael Lim
National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward
Charles L. Cywin, Amir P. Tamiz
Can a Neurosteroid Ameliorate Fragile X-Associated Tremor/Ataxia Syndrome?
Dejan B. Budimirovic
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome
J. Y. Wang, A. M. Trivedi, N. R. Carrillo, J. Yang, A. Schneider, C. Giulivi, P. Adams, F. Tassone, K. Kim, S. M. Rivera, N. Lubarr, C.-Y. Wu, R. W. Irwin, R. D. Brinton, J. M. Olichney, M. A. Rogawski, R. J. Hagerman
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study
Ariella L. G. Coler-Reilly, Tomoo Sato, Toshio Matsuzaki, Masanori Nakagawa, Masaaki Niino, Masahiro Nagai, Tatsufumi Nakamura, Norihiro Takenouchi, Natsumi Araya, Naoko Yagishita, Eisuke Inoue, Yoshihisa Yamano
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
Marta Miralles, Herena Eixarch, Marcos Tejero, Carme Costa, Keiji Hirota, A. Raul Castaño, Meritxell Puig, Gitta Stockinger, Xavier Montalban, Assumpció Bosch, Carmen Espejo, Miguel Chillon
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein
Franziska Richter, Sudhakar R. Subramaniam, Iddo Magen, Patrick Lee, Jane Hayes, Aida Attar, Chunni Zhu, Nicholas R. Franich, Nicholas Bove, Krystal De La Rosa, Jacky Kwong, Frank-Gerrit Klärner, Thomas Schrader, Marie-Françoise Chesselet, Gal Bitan
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice
Sandor Kantor, Janos Varga, Shreya Kulkarni, A. Jennifer Morton
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model
Antonio Leo, Rita Citraro, Nicola Amodio, Caterina De Sarro, Maria Eugenia Gallo Cantafio, Andrew Constanti, Giovambattista De Sarro, Emilio Russo
Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels
Yeri Kim, Jarred M. Griffin, Mohd N. Mat Nor, Jie Zhang, Peter S. Freestone, Helen V. Danesh-Meyer, Ilva D. Rupenthal, Monica Acosta, Louise F. B. Nicholson, Simon J. O’Carroll, Colin R. Green
Erratum to: Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington’s Disease Mice
Sandor Kantor, Janos Varga, Shreya Kulkarni, A. Jennifer Morton